This inventor holds 2 USPTO granted patents. Top assignee: Armour Pharmaceutical Company. Active years: 1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978
Title: Jack J Margres: Innovator in Antacid Tablet Technology
Introduction
Jack J Margres is a notable inventor based in Old Bridge, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of antacid tablets. With a total of 2 patents to his name, Margres has focused on enhancing the effectiveness and user experience of antacid products.
Latest Patents
Margres' latest patents include innovative formulations for antacid tablets. The first patent describes antacid tablets prepared by codrying certain basic aluminum bicarbonate-carbonate compositions with di- or trihydroxy alcohols. This process yields a powder material that can be formed into tablets, which provide a superior mouth feel and faster reaction velocities compared to prior antacid tablets. The second patent involves resuspendable dried antacids, which are created by drying a wet, compressed aluminum hydroxide gel. This method allows for the production of antacid compositions that can be readily resuspended to yield an opaque, aqueous suspension, reflecting the properties of the original gel.
Career Highlights
Jack J Margres is currently associated with Armour Pharmaceutical Company, where he continues to innovate in the field of pharmaceutical formulations. His work has contributed to advancements in the effectiveness of antacid products, making them more user-friendly and efficient.
Collaborations
Margres collaborates with Andrew M Rubino, a fellow professional in the pharmaceutical industry. Their partnership has likely fostered the development of innovative solutions in antacid technology.
Conclusion
Jack J Margres stands out as an inventor dedicated to improving antacid formulations. His patents reflect a commitment to enhancing the effectiveness and user experience of these products. His contributions to the field are noteworthy and continue to influence the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile